Description

Retatrutide Pre-Filled Pen — Triple GIP/GLP-1/Glucagon Receptor Agonist Formulation

Formulation Overview

The Retatrutide Pre-Filled Pen delivers a triple-hormone receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors in a single, sterile, ready-to-use device. Retatrutide is a rationally designed single-peptide molecule that achieves balanced agonism at all three receptor sites — a significant advance in multi-receptor peptide engineering.

This pre-filled format offers pre-measured, consistent dosing without the need for reconstitution, vial handling, or preparation steps — making it ideal for research protocols requiring convenience and repeatability.

Triple Mechanism Profile

• GIP Receptor (GIPR): Incretin signalling pathway involved in nutrient-dependent hormone secretion and fat metabolism signalling. GIPR is a class B GPCR coupled to Gs/cAMP pathways.
• GLP-1 Receptor (GLP-1R): Classical incretin pathway for appetite and satiety signalling, gastric function regulation, and glucose-dependent hormone release. Also a Gs-coupled class B GPCR.
• Glucagon Receptor (GCGR): Catabolic signalling pathway associated with glycogenolysis, gluconeogenesis, and energy expenditure. GCGR is primarily expressed in the liver and kidney but also found in certain brain regions.
• Integrated Effects: The simultaneous activation of three receptors creates a complex signalling environment that allows researchers to study the net effect of balanced triple-receptor agonism on metabolic signalling pathways.

Research Applications

• Triple-Receptor Pharmacology: Characterising cellular responses to simultaneous activation of three distinct GPCR systems.
• Energy Balance Studies: Investigating the interaction between incretin (anabolic/anorectic) and glucagon (catabolic) signalling pathways.
• Multi-Receptor Signalling: Studying cross-talk between GIPR, GLP-1R, and GCGR signalling cascades.
• Comparative Studies: Comparing triple-agonist effects against dual and single-agonist approaches to identify pathway-specific contributions.

Product Specifications

• Compound: Retatrutide (Triple GIP/GLP-1/Glucagon Receptor Agonist)
• Activity Profile: Balanced agonism at GIPR, GLP-1R, and GCGR
• Format: Pre-filled, sterile, ready-to-use pen
• Presentation: Sterile solution
• Quality: Manufactured under controlled conditions with quality verification
• Storage: 2-8°C (refrigerated). Protect from light.

Key Research Benefits

• Triple Receptor Agonism: Simultaneous GIP, GLP-1 and glucagon receptor activation enables research into integrated multi-pathway metabolic signalling.
• Ready-to-Use Format: Sterile, pre-measured solution — no reconstitution or vial handling required, reducing protocol variables.
• Energy Balance Research: Combines anabolic incretin pathways with catabolic glucagon signalling for energy metabolism studies.
• Consistent Dosing: Pre-filled pen delivers precise, reproducible doses for longitudinal research protocols.

How to Use (Research Application)

For experienced laboratory personnel only. This product is a sterile, ready-to-use pre-filled pen for research applications — no reconstitution required.

• Remove the pen from refrigeration and allow it to reach room temperature before use.
• Select the required dose on the pen dial as defined in your research protocol.
• Use sterile technique and attach a fresh needle for each administration.
• Rotate administration sites according to your research protocol.
• Store the pen at 2–8°C when not in use. Do not freeze. Dispose of used needles safely.

Important Notice

This product is for research and laboratory purposes only. Not for human or veterinary consumption. Not for medical use. Not evaluated by SAHPRA. For experienced researchers only. Information is for educational reference. Researchers must comply with all applicable regulations.